Enter at least 4 characters

1 results showing for: 'moroctocog alfa [recombinant factor viii]'

[Xpharm]
  • Inj 250 iu prefilled syringe
    • Brand Fully subsidised brand. Xyntha
    • Pharmacode2424339
    • Subsidy $287.50
    • Measure / Qty per 1
  • Inj 500 iu prefilled syringe
    • Brand Fully subsidised brand. Xyntha
    • Pharmacode2424347
    • Subsidy $575.00
    • Measure / Qty per 1
  • Inj 1,000 iu prefilled syringe
    • Brand Fully subsidised brand. Xyntha
    • Pharmacode2424355
    • Subsidy $1150.00
    • Measure / Qty per 1
  • Inj 2,000 iu prefilled syringe
    • Brand Fully subsidised brand. Xyntha
    • Pharmacode2424363
    • Subsidy $2300.00
    • Measure / Qty per 1
  • Inj 3,000 iu prefilled syringe
    • Brand Fully subsidised brand. Xyntha
    • Pharmacode2424371
    • Subsidy $3450.00
    • Measure / Qty per 1

For patients with haemophilia. Rare Clinical Circumstances Brand of short half-life recombinant factor VIII. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group, subject to criteria.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply